Terug
Dagbereik
€ 16,43
€ 16,43
52-Weeksbereik
€ 11,16
€ 17,54
Volume
100
50D / 200D Gem.
€ 16,37
/
€ 14,41
Vorige Slotkoers
€ 16,43
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 36,7 | 0,4 |
| P/B | 2,3 | 2,9 |
| ROE % | 7,4 | 3,7 |
| Net Margin % | 4,4 | 3,8 |
| Rev Growth 5Y % | 10,7 | 10,0 |
| D/E | 2,0 | 0,2 |
Belangrijkste Punten
Revenue grew 10,71% annually over 5 years — strong growth
Earnings grew 15,85% over the past year
Negative free cash flow of -42,83M
P/E of 36,70 — premium valuation
ROIC of 3,40% — low return on invested capital
Groei
Revenue Growth (5Y)
10,71%
Revenue (1Y)12,42%
Earnings (1Y)15,85%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
7,42%
ROIC3,40%
Net Margin4,43%
Op. Margin9,68%
Veiligheid
Debt / Equity
1,99
Current Ratio0,51
Interest Coverage2,15
Waardering
P/E Ratio
36,70
P/B Ratio2,27
EV/EBITDA30,25
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,42% | Revenue Growth (3Y) | 13,07% |
| Earnings Growth (1Y) | 15,85% | Earnings Growth (3Y) | 151,43% |
| Revenue Growth (5Y) | 10,71% | Earnings Growth (5Y) | 21,16% |
| Profitability | |||
| Revenue (TTM) | 1,00B | Net Income (TTM) | 44,49M |
| ROE | 7,42% | ROA | 1,76% |
| Gross Margin | 13,97% | Operating Margin | 9,68% |
| Net Margin | 4,43% | Free Cash Flow (TTM) | -42,83M |
| ROIC | 3,40% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,99 | Current Ratio | 0,51 |
| Interest Coverage | 2,15 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 36,70 | P/B Ratio | 2,27 |
| P/S Ratio | 1,63 | PEG Ratio | -4,48 |
| EV/EBITDA | 30,25 | Dividend Yield | 0,04% |
| Market Cap | 1,63B | Enterprise Value | 2,94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,00B | 893,16M | 785,37M | 718,59M | 668,49M |
| Net Income | 44,49M | 38,40M | 7,04M | 10,67M | 20,65M |
| EPS (Diluted) | 0,48 | 0,53 | 0,10 | 0,15 | 0,31 |
| Gross Profit | 140,24M | 893,16M | 146,31M | 91,00M | 81,85M |
| Operating Income | 97,24M | 103,19M | 115,40M | 38,04M | 56,83M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,53B | 1,86B | 1,70B | 1,68B | 1,61B |
| Total Liabilities | 1,82B | 1,38B | 1,32B | 1,25B | 1,20B |
| Shareholders' Equity | 718,94M | 480,72M | 373,77M | 434,69M | 405,85M |
| Total Debt | 1,43B | 1,01B | 1,01B | 977,96M | 950,28M |
| Cash & Equivalents | 119,56M | 127,20M | 24,40M | 38,05M | 29,05M |
| Current Assets | 177,73M | 164,87M | 60,70M | 83,76M | 95,74M |
| Current Liabilities | 351,15M | 388,11M | 508,46M | 336,71M | 230,47M |